Highbridge Capital Management’s Celgene Corp CELG Stock Holding History

Highbridge Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-187,065	Closed	-$17.6M	–	376
2019 Q1	$17.6M	Buy	+187,065	New	+$16.4M	0.54%	55
2018 Q4	–	Sell	-11,070	Closed	-$991K	–	598
2018 Q3	$991K	Sell	11,070 -114,759	-91%	-$10.1M	0.02%	392
2018 Q2	$9.99M	Buy	125,829 +25,829	+26%	+$2.14M	0.2%	136
2018 Q1	$8.92M	Sell	100,000 -22,053	-18%	-$2.12M	0.14%	169
2017 Q4	$12.7M	Buy	+122,053	New	+$13.8M	0.23%	119
2017 Q1	–	Sell	-3,264	Closed	-$378K	–	1929
2016 Q4	$378K	Sell	3,264 -3,829	-54%	-$426K	0.01%	877
2016 Q3	$741K	Sell	7,093 -2,035	-22%	-$220K	0.01%	646
2016 Q2	$900K	Sell	9,128 -46,743	-84%	-$4.84M	0.01%	645
2016 Q1	$5.59M	Buy	+55,871	New	+$5.75M	0.09%	250
2015 Q4	–	Sell	-24,389	Closed	-$2.82M	–	2097
2015 Q3	$2.64M	Buy	+24,389	New	+$3.03M	0.04%	468
2015 Q2	–	Sell	-6,820	Closed	-$780K	–	1931
2015 Q1	$786K	Sell	6,820 -12,304	-64%	-$1.47M	0.01%	823
2014 Q4	$2.14M	Buy	19,124 +6,755	+55%	+$712K	0.03%	467
2014 Q3	$1.17M	Buy	+12,369	New	+$1.12M	0.02%	613
2014 Q2	–	Sell	-768,208	Closed	-$53.6M	–	1471
2014 Q1	$53.6M	Buy	768,208 +752,720	+4,860%	+$59.6M	0.68%	34
2013 Q4	$1.31M	Sell	15,488 -281,094	-95%	-$22.2M	0.02%	472
2013 Q3	$22.9M	Sell	296,582 -467,124	-61%	-$32.7M	0.24%	127
2013 Q2	$44.7M	Buy	+763,706	New	+$46M	0.44%	36

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Highbridge Capital Management's CELG Position: Q2 2019 in Review

Highbridge Capital Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 187,065 shares — an estimated $17.6M sold.

Highbridge Capital Management first reported a position in CELG in Q2 2013 and held it in 17 quarters. The position peaked at $53.6M in Q1 2014. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Highbridge Capital Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Highbridge Capital Management sold 187,065 Celgene Corp shares in Q2 2019, an estimated $17.6M.
Highbridge Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 17 quarters.
Highbridge Capital Management's Celgene Corp position peaked at $53.6M in Q1 2014.
1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Highbridge Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.